149 related articles for article (PubMed ID: 18320775)
1. [Prasugrel versus clopidogrel. From the American Heart Association meeting, 2007].
Schaerlig E
Rev Med Suisse; 2008 Feb; 4(144):434-5. PubMed ID: 18320775
[No Abstract] [Full Text] [Related]
2. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
Morrow DA; Wiviott SD; White HD; Nicolau JC; Bramucci E; Murphy SA; Bonaca MP; Ruff CT; Scirica BM; McCabe CH; Antman EM; Braunwald E
Circulation; 2009 Jun; 119(21):2758-64. PubMed ID: 19451347
[TBL] [Abstract][Full Text] [Related]
3. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
[TBL] [Abstract][Full Text] [Related]
4. Prasugrel versus clopidogrel.
Serebruany V
N Engl J Med; 2008 Mar; 358(12):1298; author reply 1299-301. PubMed ID: 18354110
[No Abstract] [Full Text] [Related]
5. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial.
Michelson AD; Frelinger AL; Braunwald E; Downey WE; Angiolillo DJ; Xenopoulos NP; Jakubowski JA; Li Y; Murphy SA; Qin J; McCabe CH; Antman EM; Wiviott SD;
Eur Heart J; 2009 Jul; 30(14):1753-63. PubMed ID: 19435740
[TBL] [Abstract][Full Text] [Related]
7. A potent alternative to clopidogrel emerges. Prasugrel appears to lower heart attack risk for patients with acute coronary syndrome.
Heart Advis; 2010 May; 13(5):6. PubMed ID: 22816152
[No Abstract] [Full Text] [Related]
8. Efficacy and safety of prasugrel compared with clopidogrel in patients with acute coronary syndromes: results of TRITON-TIMI 38 trials.
Mariani M; Mariani G; De Servi S
Expert Rev Cardiovasc Ther; 2009 Jan; 7(1):17-23. PubMed ID: 19105763
[TBL] [Abstract][Full Text] [Related]
9. A perspective on the efficacy and safety of intensive antiplatelet therapy in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38.
Wiviott SD; Braunwald E; Murphy SA; Antman EM;
Am J Cardiol; 2008 May; 101(9):1367-70. PubMed ID: 18435974
[No Abstract] [Full Text] [Related]
10. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
[TBL] [Abstract][Full Text] [Related]
11. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
[TBL] [Abstract][Full Text] [Related]
12. Excess rates of nonfatal myocardial infarction in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel (preventing clinical events or chasing enzymatic ghosts?).
Serebruany VL
Am J Cardiol; 2008 May; 101(9):1364-6. PubMed ID: 18435973
[No Abstract] [Full Text] [Related]
13. [Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?].
Silber S; Helms TM; Garlichs C; Arntz HR; Weil J; Ince H; Klingenheben T; Hoffmann S; Boudriot E; Steiger H; Zugck C
Dtsch Med Wochenschr; 2011 Apr; 136(15):782-5. PubMed ID: 21432747
[No Abstract] [Full Text] [Related]
14. Prasugrel (Effient) vs. clopidogrel (Plavix).
Med Lett Drugs Ther; 2009 Sep; 51(1320):69-70. PubMed ID: 19738549
[TBL] [Abstract][Full Text] [Related]
15. Predictors of bleeding in acute coronary syndromes with clopidogrel and prasugrel.
Rodriguez L; Conde D; Lalor N; Elissamburu P; Trivi M
Am J Emerg Med; 2013 Aug; 31(8):1287. PubMed ID: 23769852
[No Abstract] [Full Text] [Related]
16. Predictors of myocardial infarction after an acute coronary syndrome with clopidogrel and prasugrel.
Lalor N; Conde D; Rodriguez L; Elissamburu P; Trivi M
Am J Emerg Med; 2013 Aug; 31(8):1287-8. PubMed ID: 23806726
[No Abstract] [Full Text] [Related]
17. Is prasugrel more effective than clopidogrel in patients with acute coronary syndrome scheduled for PCI?
Graber MA; Dachs R; Darby-Stewart A
Am Fam Physician; 2008 Dec; 78(11):1252-3. PubMed ID: 19069017
[No Abstract] [Full Text] [Related]
18. Prasugrel versus clopidogrel.
von Lewinski F; Riggert J; Paulus W
N Engl J Med; 2008 Mar; 358(12):1299; author reply 1299-301. PubMed ID: 18357639
[No Abstract] [Full Text] [Related]
19. Prasugrel for acute coronary syndromes: faster, more potent, but higher bleeding risk.
Lazar LD; Lincoff AM
Cleve Clin J Med; 2009 Dec; 76(12):707-14. PubMed ID: 19952295
[TBL] [Abstract][Full Text] [Related]
20. Oral antiplatelet agents clopidogrel and prasugrel for the prevention of cardiovascular events.
Passacquale G; Ferro A
BMJ; 2011 Jun; 342():d3488. PubMed ID: 21685436
[No Abstract] [Full Text] [Related]
[Next] [New Search]
